姓名：黄亚芳
职称：副教授
研究方向：药品评价与监管、数字健康与智慧医疗
电子邮箱：[email protected]
社会任职：
1.《家庭医学与社区健康》青年编委
近五年科研成果：
1. Jinjia Zhong, Ting Zhu, Yafang Huang*. Reporting quality of artificial intelligence intervention in randomized controlled trials in primary care: a systematic review and meta-epidemiological study. J Med Internet Res. 2025; 27:e56774. doi: 10.2196/56774.
2. Yafang Huang*, Weiyi Xiong, Jingwei Zhao, Wentao Li, Li Ma, Hao Wu*. Early phase clinical trial played a critical role in the Food and Drug Administration-approved indications for targeted anticancer drugs: a cross-sectional study from 2012 to 2021. J Clin Epidemiol, 2023;157:74-82. doi: 10.1016/j.jclinepi.2023.03.006.
3. Yafang Huang*, Weiyi Xiong, Li Ma, Hao Wu. A cross-sectional study of the FDA approved indications and supporting pivotal trials of small-molecular kinase inhibitors in cancer therapies with the biomarker of cancer driver gene. Int J Cancer, 2022;151(12):2107-2114. DOI: 10.1002/ijc.34222
4. Ting Zhu, Jinjia Zhong, Yafang Huang*. Cancer drugs approved based on surrogate endpoint: a retrospective observational study in the United States and China. Cancer Medicine. 2025; 14(8):e70864. doi: 10.1002/cam4.70864.
5. Yafang Huang*, Jinqiu Yuan. Improvement of assessment in surrogate endpoint and safety outcome of single-arm trials for anticancer drugs. Expert Rev Clin Pharmacol.2024,17(5-6):477-487.doi: 10.1080/17512433.2024.2344669.
6. 黄亚芳，相彤，吴浩*. 全民健康覆盖时代下的数字疗法：基层医疗的机遇与挑战.中华全科医师杂志,2024,23(2):101-105.
7. 朱婷，黄亚芳*，相彤，吴浩. 基于认知行为治疗的数字疗法在社区慢性病管理中的应用及展望. 中华全科医学,2024,22(3): 357-360.
8. 钟锦佳，李文涛，黄亚芳*，吴浩. 初级保健领域基于机器学习预测模型研究的设计特征与方法学质量：范围综述. 中国全科医学, 2024,27(10):1271-1276.
9. 耿佳音, 黄亚芳*, 刘艳丽. 老年患者社区门诊潜在不适当处方影响因素分析. 中国全科医学, 2022, 25 (16): 1969-1977.
10. 查博文，朱尹凡，石阳，张雪晗，黄亚芳*. 交互式短信对2型糖尿病管理效果的系统评价. 中国循证医学杂志, 2021, 21 (8): 929-935.
